Annual ROE
-50.25%
+62.29%+55.35%
September 1, 2024
Summary
- As of February 7, 2025, DRUG annual return on equity is -50.25%, with the most recent change of +62.29% (+55.35%) on September 1, 2024.
- During the last 3 years, DRUG annual ROE has fallen by -5.27% (-11.72%).
- DRUG annual ROE is now -11.72% below its all-time high of -44.98%, reached on September 30, 2021.
Performance
DRUG ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-47.65%
+10.67%+18.30%
September 1, 2024
Summary
- As of February 7, 2025, DRUG quarterly return on equity is -47.65%, with the most recent change of +10.67% (+18.30%) on September 1, 2024.
- Over the past year, DRUG quarterly ROE has increased by +43.45% (+47.69%).
- DRUG quarterly ROE is now -68.32% below its all-time high of -28.31%, reached on March 31, 2021.
Performance
DRUG Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
DRUG ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +55.4% | +47.7% |
| 3 y3 years | -11.7% | +47.7% |
| 5 y5 years | +23.4% | +47.7% |
DRUG ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.7% | +66.9% | at high | +64.9% |
| 5 y | 5-year | -11.7% | +66.9% | -68.3% | +64.9% |
| alltime | all time | -11.7% | +66.9% | -68.3% | +64.9% |
Bright Minds Biosciences ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | -50.25%(-55.3%) | -47.65%(-18.3%) |
| Jun 2024 | - | -58.32%(-27.1%) |
| Mar 2024 | - | -79.95%(-12.2%) |
| Dec 2023 | - | -91.10%(+5.9%) |
| Sep 2023 | -112.54%(-25.9%) | -86.02%(-7.8%) |
| Jun 2023 | - | -93.32%(-10.9%) |
| Mar 2023 | - | -104.78%(-15.6%) |
| Dec 2022 | - | -124.16%(-8.6%) |
| Sep 2022 | -151.95% | -135.85%(+21.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -111.71%(+18.4%) |
| Mar 2022 | - | -94.37%(+48.7%) |
| Dec 2021 | - | -63.47%(+25.1%) |
| Sep 2021 | -44.98%(-31.4%) | - |
| Sep 2021 | - | -50.74%(+2.3%) |
| Jun 2021 | - | -49.59%(+75.2%) |
| Mar 2021 | - | -28.31%(-63.9%) |
| Dec 2020 | - | -78.36%(+18.7%) |
| Sep 2020 | -65.60% | - |
| Sep 2020 | - | -65.99% |
FAQ
- What is Bright Minds Biosciences annual return on equity?
- What is the all time high annual ROE for Bright Minds Biosciences?
- What is Bright Minds Biosciences annual ROE year-on-year change?
- What is Bright Minds Biosciences quarterly return on equity?
- What is the all time high quarterly ROE for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly ROE year-on-year change?
What is Bright Minds Biosciences annual return on equity?
The current annual ROE of DRUG is -50.25%
What is the all time high annual ROE for Bright Minds Biosciences?
Bright Minds Biosciences all-time high annual return on equity is -44.98%
What is Bright Minds Biosciences annual ROE year-on-year change?
Over the past year, DRUG annual return on equity has changed by +62.29% (+55.35%)
What is Bright Minds Biosciences quarterly return on equity?
The current quarterly ROE of DRUG is -47.65%
What is the all time high quarterly ROE for Bright Minds Biosciences?
Bright Minds Biosciences all-time high quarterly return on equity is -28.31%
What is Bright Minds Biosciences quarterly ROE year-on-year change?
Over the past year, DRUG quarterly return on equity has changed by +43.45% (+47.69%)